摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

bis(2-ethoxyethyl)benzylphosphine | 166770-88-3

中文名称
——
中文别名
——
英文名称
bis(2-ethoxyethyl)benzylphosphine
英文别名
benzylbis(2-ethoxyethyl)phosphane;benzylbis(2-ethoxyethyl)phosphine;Benzyl-bis(2-ethoxyethyl)phosphane
bis(2-ethoxyethyl)benzylphosphine化学式
CAS
166770-88-3
化学式
C15H25O2P
mdl
——
分子量
268.336
InChiKey
LTHFDXFAHBPADC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    18
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    bis(2-ethoxyethyl)benzylphosphine 、 sodium hydroxide 作用下, 以 乙醇乙腈 为溶剂, 生成 ethane-1,2-diylbis(bis(2-ethoxyethyl)phosphine oxide)
    参考文献:
    名称:
    [EN] AN IMPROVED PROCESS FOR THE PREPARATION OF TETROFOSMIN OR ACID ADDITION SALT THEREOF
    [FR] PROCÉDÉ AMÉLIORÉ POUR LA PRÉPARATION DE TÉTROFOSMINE OU D'UN SEL DE QUALITÉ PHARMACEUTIQUE DE CELLE-CI
    摘要:
    本发明涉及一种改进的制备四氟硫醚或其酸盐的方法。本发明还涉及制备四氟硫醚二磺基水杨酸盐的方法。此外,本发明还提供了四氟硫醚二磺基水杨酸盐的J形态的多晶形式。
    公开号:
    WO2018162964A1
  • 作为产物:
    描述:
    diethyl benzylphosphonate 在 lithium aluminium tetrahydride 作用下, 生成 bis(2-ethoxyethyl)benzylphosphine
    参考文献:
    名称:
    Synthesis of the myoview™ ligand, [bisphosphinoethane-1,2-14C]tetrofosmin
    摘要:
    通过将 1,2-二溴[U-14C]乙烷与双(2-乙氧基乙基)苄基膦(1)反应,可以很容易地引入[双膦乙烷-1,2-14C]四磷酸盐配体中的碳-14 放射性标记。该配体转化为 Myoview™ 配体的总产率为 45%。这种放射合成技术对获得监管机构的上市许可非常重要,并使 Myoview™ 成为当今主要的心脏成像剂之一。版权所有 © 2007 John Wiley & Sons, Ltd. 保留所有权利。
    DOI:
    10.1002/jlcr.1199
点击查看最新优质反应信息

文献信息

  • Complexes of electropositive metals with a hemilabile ether phosphine. Crystal structures of [TiCl4L], [FeL2(O3SCF3)2] and [Mo(CO)3L2][L = PhCH2P(CH2CH2OEt)2]
    作者:Steven J. Chadwell、Simon J. Coles、Peter G. Edwards、Michael B. Hursthouse
    DOI:10.1039/dt9960001105
    日期:——
    New complexes containing some early transition metals with benzylbis(2-ethoxyethyl)phosphine (L) have been prepared. Reaction of this potentially hemilabile terdentate ligand with TiCl4 afforded [TiCl4L]1. The crystal structure shows the metal to have a distorted-octahedral geometry, where the ligand acts as a P,O-bonding chelate. Reaction of 1 with AgBF4 and AgO3SCF3 afforded yellow oils which could not be fully characterised, but are tentatively assigned as [TiCl3L][BF4] and [TiCl3L][O3SCF3] respectively. The reaction of [Cr(MeCN)3(CO)3] with L resulted in the formation of [Cr(CO)4L2]2 in poor yield. This complex can be prepared in high yield by the reaction of [Cr(MeCN)2(CO)4] with L. The reaction of [M(CO)3(C6H3Me3-2,4,6)](M = Mo or W) with L gave the complex fac-[Mo(CO)3L2]3 and [M(CO)4L2](M = Mo 4 or W 5) depending upon reaction conditions. The crystal structure of 3 shows the metal to have a distorted-octahedral geometry, where one L bonds as a P,O chelate and the other as a P-donor. 31P-1H} NMR spectroscopy indicates this complex to be fluxional in solution, where the two ligands readily interchange at high temperatures. The iron(II) complex [FeL2(O3SCF3)2]6 was prepared by the reaction of L and FeCl2·4H2O with AgO3SCF3. Its crystal structure shows the metal to have a distorted-octahedral geometry with trans ligands (through phosphorus and oxygen) and trans-co-ordinating triflates.
    已制备出含有一些早期过渡属与苄基双(2-乙氧基乙基)膦(L)的新络合物。这种潜在的半不稳定三齿配体与 TiCl4 反应得到 [TiCl4L]1。晶体结构显示该属具有扭曲的八面体几何形状,其中配体充当 P,O 键合螯合物。 1 与 AgBF4 和 AgO3SCF3 反应得到黄色油状物,无法完全表征,但暂时分别指定为 [TiCl3L][BF4] 和 [TiCl3L][O3SCF3]。 [Cr(MeCN)3(CO)3] 与 L 的反应导致形成 [Cr(CO)4L2]2,但产率较低。该配合物可以通过 [Cr(MeCN)2(CO)4] 与 L 的反应以高产率制备。 [M(CO)3(C6H3Me3-2,4,6)](M = Mo 或W) 与 L 得到配合物 fac-[Mo(CO)3L2]3 和 [M(CO)4L2](M = Mo 4 或 W 5),具体取决于反应条件。 3 的晶体结构显示该属具有扭曲的八面体几何形状,其中一个 L 作为 P,O 螯合物键合,另一个作为 P-供体。 31P-1H} NMR 光谱表明该配合物在溶液中是流动的,其中两个配体在高温下很容易互换。 L和FeCL2·4H2O与AgO3SCF3反应制备了(II)配合物[FeL2(O3SCF3)2]6。其晶体结构显示该属具有带有反式配体(通过和氧)和反式配位三氟甲磺酸酯的扭曲八面体几何形状。
  • Synthesis and characterization of group 10 metal complexes with a new trifunctional ether phosphine. The X-ray crystal structures of bis[bis(2-ethoxyethyl)benzylphosphine] dichloronickel(II) and bis[bis(2-ethoxyethyl)benzylphosphine]chlorophenylnickel(II)
    作者:Steven J. Chadwell、Simon J. Coles、Peter G. Edwards、Michael B. Hursthouse、Ahmed Imran
    DOI:10.1016/0277-5387(94)00343-d
    日期:1995.4
    The synthesis and characterizations of the new trifunctional ligand bis(2-ethoxyethyl)benzylphosphine (OPO ; 1) and some new group 10 metal complexes are described. Reactions of this potentially hemilabile ligand with the nickel, palladium and platinum chlorides have been studied, resulting in isolation of the series, MCl2(OPO)2, where M = Ni (2), Pd (3) or Pt (4). The X-ray crystal structure of 2
    摘要描述了新型三官能配体双(2-乙氧基乙基)苄基膦(OPO; 1)以及一些新型的第10族属配合物的合成和表征。已经研究了这种可能具有半挥发性的配体氯化镍氯化铂的反应,从而分离出MCl2(OPO)2系列,其中M = Ni(2),Pd(3)或Pt(4)。2的X射线晶体结构显示属具有正方形平面反式排列,其中配位体通过中心通过η1-键键合。化合物3和4也是反式的。使用NaBPh4尝试与形成氧/螯合物,生成了新的反式NiClPh(OPO)2络合物(5),通过X射线晶体学显示其为方形平面,带有反和苯基基团。还准备了2的二类似物(6),
  • Process for the preparation of tetrofosmin or acid salt thereof
    申请人:Jubilant Generics Limited
    公开号:US10836781B2
    公开(公告)日:2020-11-17
    The present invention relates to an improved process for the preparation of tetrofosmin or acid addition salt thereof. The present invention also relates to the process for the preparation of tetrofosmin disulfosalicylate salt. Further the present invention also provides the polymorphic form J of disulfosalicylate salt of tetrofosmin.
    本发明涉及一种制备四磷胺或其酸加成盐的改进工艺。本发明还涉及四螨嗪磺酸水杨酸盐的制备工艺。此外,本发明还提供了四磷胺磺酸水杨酸盐的多晶型J。
  • Chelating ether–phosphine complexes of the cobalt group metals. Crystal structures of bis[benzylbis(2-ethoxyethyl)-phosphine]-bis(trifluoromethanesulfonato)cobalt(<scp>II</scp>) and -trichlororhodium(<scp>III</scp>)
    作者:Steven J. Chadwell、Simon J. Coles、Peter G. Edwards、Michael B. Hursthouse
    DOI:10.1039/dt9950003551
    日期:——
    New Group 9 metal complexes have been prepared using the trifunctional ligand benzylbis(2-ethoxyethyl)phosphine (L). Reactions of this potentially hemilabile ligand with CoCl2, and CoCl2 . 6H(2)O with AgCF3SO3, have been studied, resulting in the isolation of [CoCl(2)L(2)] 1 and [CoL(2)(O3SCF3)(2)] 2 respectively. In the former complex L acts as a monodentate P-bonding ligand with the metal adopting a tetrahedral geometry, but in the latter it acts as an O,P chelate. The crystal structure for 2 has been determined and shows the metal to have a distorted-octahedral geometry with trans ligands (P and O) and trans triflates. The P-31-H-1} NMR spectrum of 2 suggests the formation of a dimeric species in solution, Reactions of L with RhCl3 . 3H(2)O, [RhCl(CO)(2)}(2)] and [RhCl(cod)}(2)] (cod = cycloocta-1,5-diene) resulted in the isolation of [RhCl(3)L(2)] 3, [RhCl(CO)L(2)] 4 and [RhCl(cod)L] 5 respectively, where L acts as a monodentate P-bonding ligand in 4 and 5. Complex;4 is shown to be trans by NMR studies. In 3 the ligand bonds as a monodentate phosphorus donor in one case and as a bidentate O,P chelate in the other. The crystal structure of 3 has been determined and shows the metal to have a slightly distorted-octahedral mer arrangement with cis phosphorus donors. The fluxional nature of this complex has been monitored by variable-temperature P-31-(H-1) and H-1 NMR spectroscopy which shows that these ligands readily interchange at high temperatures. The iridium analogue of 5 has been prepared from [IrCl(cod)}(2)] resulting in the isolation of [IrCl(cod)L] 6. The reaction of 3 with cyclohexene gave an unstable alkene complex 7 which could not be isolated. but was identified by variable-temperature P-31-H-1} NMR studies.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫